{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:12:55Z","timestamp":1789701175261,"version":"4.0.1"},"reference-count":40,"publisher":"Baishideng Publishing Group Inc.","issue":"44","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2006]]},"DOI":"10.3748\/wjg.v12.i44.7118","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T07:53:14Z","timestamp":1458114794000},"page":"7118","source":"Crossref","is-referenced-by-count":23,"title":["Genetic vaccination with Flt3-L and GM-CSF as adjuvants: Enhancement of cellular and humoral immune responses that results in protective immunity in a murine model of hepatitis C virus infection"],"prefix":"10.3748","volume":"12","author":[{"given":"Jens","family":"Encke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.09.040191.001415"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00449-4"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Pulendran B, Banchereau J, Burkeholder S, Kraus E, Guinet E, Chalouni C, Caron D, Maliszewski C, Davoust J, Fay J. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol 2000;165:566-572.","DOI":"10.4049\/jimmunol.165.1.566"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(00)01794-4"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950017130"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Péron JM, Esche C, Subbotin VM, Maliszewski C, Lotze MT, Shurin MR. FLT3-ligand administration inhibits liver metastases: role of NK cells. J Immunol 1998;161:6164-6170.","DOI":"10.4049\/jimmunol.161.11.6164"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2001.01180.x"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1999.0540"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nm0597-526"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nm0896-888"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000024971"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1086\/315229"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5388.476"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/BF00870264"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Iwasaki A, Torres CA, Ohashi PS, Robinson HL, Barber BH. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 1997;159:11-14.","DOI":"10.4049\/jimmunol.159.1.11"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.9.1481"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.1.169"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/nm1096-1122"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.010"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-59605-6_3"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903113401001"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nature04081"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Geissler M, Gesien A, Tokushige K, Wands JR. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol 1997;158:1231-1237.","DOI":"10.4049\/jimmunol.158.3.1231"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Geissler M, Gesien A, Wands JR. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids. J Immunol 1997;159:5107-5113.","DOI":"10.4049\/jimmunol.159.10.5107"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Encke J, zu Putlitz J, Geissler M, Wands JR. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J Immunol 1998;161:4917-4923.","DOI":"10.4049\/jimmunol.161.9.4917"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/368643a0"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckmann MP, McKenna HJ. Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 1994;83:2795-2801.","DOI":"10.1182\/blood.V83.10.2795.2795"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00448-2"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1126\/science.1062060"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Garza KM, Agersborg SS, Baker E, Tung KS. Persistence of physiological self antigen is required for the regulation of self tolerance. J Immunol 2000;164:3982-3989.","DOI":"10.4049\/jimmunol.164.8.3982"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/BF00870263"},{"key":"ref32","unstructured":"Chen K, Braun S, Lyman S, Fan Y, Traycoff CM, Wiebke EA, Gaddy J, Sledge G, Broxmeyer HE, Cornetta K. Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model. Cancer Res 1997;57:3511-3516."},{"key":"ref33","unstructured":"Esche C, Subbotin VM, Maliszewski C, Lotze MT, Shurin MR. FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma. Cancer Res 1998;58:380-383."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/nm0697-625"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301160"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1089\/10430340050015734"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Sin JI, Kim JJ, Arnold RL, Shroff KE, McCallus D, Pachuk C, McElhiney SP, Wolf MW, Pompa-de Bruin SJ, Higgins TJ. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge. J Immunol 1999;162:2912-2921.","DOI":"10.4049\/jimmunol.162.5.2912"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204542"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Juan TS, McNiece IK, Van G, Lacey D, Hartley C, McElroy P, Sun Y, Argento J, Hill D, Yan XQ. Chronic expression of murine flt3 ligand in mice results in increased circulating white blood cell levels and abnormal cellular infiltrates associated with splenic fibrosis. Blood 1997;90:76-84.","DOI":"10.1182\/blood.V90.1.76"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Mwangi W, Brown WC, Lewin HA, Howard CJ, Hope JC, Baszler TV, Caplazi P, Abbott J, Palmer GH. DNA-encoded fetal liver tyrosine kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbred animals. J Immunol 2002;169:3837-3846.","DOI":"10.4049\/jimmunol.169.7.3837"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T07:02:08Z","timestamp":1692255728000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v12\/i44\/7118.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006]]},"references-count":40,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v12.i44.7118","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2006]]}}}